Arcturus Therapeutics Ltd. Operating Cash Flow
Arcturus Therapeutics Ltd. reported Operating Cash Flow of -$5.41 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2019-05-13
- Arcturus Therapeutics Ltd. net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$5.41M.
- Arcturus Therapeutics Ltd. net cash provided by (used in) operating activities for the quarter ending 2018-12-31 was -$5.76M, a 215.24% decline year-over-year.
- Arcturus Therapeutics Ltd. net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$6.79M.
- Arcturus Therapeutics Ltd. net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$7.84M.
- Arcturus Therapeutics Ltd. net cash provided by (used in) operating activities for fiscal 2018 was -$20.76M.
- Arcturus Therapeutics Ltd. net cash provided by (used in) operating activities for fiscal 2017 was -$460.00K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 71 month |
|---|---|---|---|---|---|
| 2019-03-31 | -$5.41M 10-Q · filed 2019-05-13 | -$11.17M derived: sum of 2 quarters · filed 2019-05-13 | -$17.97M derived: sum of 3 quarters · filed 2019-05-13 | -$25.81M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-12-31 | -$5.76M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$12.56M derived: sum of 2 quarters · filed 2019-03-18 | -$20.40M derived: sum of 3 quarters · filed 2019-03-18 | -$20.76M 10-K · filed 2019-03-18 | |
| 2018-09-30 | -$6.79M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | -$14.64M derived: sum of 2 quarters · filed 2018-11-07 | -$15.00M 6-K · filed 2018-11-07 | -$10.00M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-06-30 | -$7.84M derived: 6-K 6 month − 10-Q 3 month · filed 2018-09-28 | -$8.20M 6-K · filed 2018-09-28 | -$3.20M derived: sum of 3 quarters · filed 2019-05-13 | -$4.93M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-03-31 | -$361.00K 10-Q · filed 2019-05-13 | $4.64M derived: sum of 2 quarters · filed 2019-05-13 | $2.91M derived: sum of 3 quarters · filed 2019-05-13 | ||
| 2017-12-31 | $5.00M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $3.27M derived: sum of 2 quarters · filed 2019-03-18 | -$460.00K 10-K · filed 2019-03-18 | ||
| 2017-09-30 | -$1.73M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | -$5.46M 6-K · filed 2018-11-07 | |||
| 2017-06-30 | -$3.73M 6-K · filed 2018-09-28 | ||||
| 2016-12-31 | -$19.24M 20-F · filed 2017-04-28 | ||||
| 2015-12-31 | -$18.15M 20-F · filed 2017-04-28 | ||||
| 2014-12-31 | -$28.33M 20-F · filed 2017-04-28 | ||||
| 2013-12-31 | -$7.35M 20-F · filed 2016-03-04 | -$12.98M 20-F · filed 2014-03-28 | |||
| 2012-12-31 | -$1.58M 20-F · filed 2015-02-27 | ||||
| 2011-12-31 | -$2.36M 20-F · filed 2014-03-28 |